바이오플러스

099430KOSDAQ기초 의약물질 제조업

57.6 / 100

Reference Date: 2026-07-24

Financial Score23.0 / 40

News Sentiment20.6 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: PER is significantly undervalued vs. peers but Operating Profit is on a declining trend. Declined 14.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

BioPlus is a company specializing in the development and sale of medical devices, bio-pharmaceuticals, and bio-cosmetics, leveraging technologies such as MDM and temperature-sensitive materials to enhance product performance. To expand globally, the company has established a foreign subsidiary in Hainan, China, and operates a large-scale factory in Chungcheongbuk, South Korea, focusing on improving profitability.

Number of Employees

187people

Average Salary

60.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

14.55Industry Average 25.446.5Point

Lower than industry avg (good)

PBR

1.16Industry Average 1.264.0Point

In line with industry avg

ROE

11.67Industry Average -6.033.5Point

Well below industry avg

Debt Ratio

6.54Industry Average 6.624.0Point

In line with industry avg

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲19.5% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼26.1% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 15.2% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 3Neutral 0Negative 1Average Sentiment Score 82.5

Positive
바이오플러스, 내달 '휴그로' 활용한 체험형 뷰티 공간 연다
바이오플러스는 휴그로 플랫폼을 활용해 소비자 체험형 뷰티 공간을 개설하여 브랜드 인지도와 직접적인 고객 참여를 높여 긍정적인 시장 반응을 기대.
Positive
바이오플러스, 바이오 원료 기반 고기능성 화장품 사업 강화
바이오플러스는 유전자재조합 콜라겐 등 차세대 바이오 소재 개발로 고기능성 화장품 사업을 확장하며 긍정적인 시장 반응을 얻고 있다.
Negative
코스닥 바이오 주가 급락에…커지는 '전환사채 리스크'
바이오플러스 주가 하락은 전환사채 리스크 증가로 인한 재무 부담 확대로 인해 부정적 영향을 받고 있다.

Detailed Momentum

52-week position1.0Point

Near 52w low (4%, downtrend)

Current 3,680Won52-week high 7,68052-week low 3,510

1-month return1.0Point

1m -14.12% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0